World Bronchiectasis Conference

The World Bronchiectasis Conference (WBC) is set to take place in Hanover, Germany, marking a significant return to the city where this influential global movement began a decade ago. The conference will serve as a pivotal gathering for clinicians, scientists, allied health professionals, patient leaders, and industry stakeholders, all united in the goal of improving outcomes for individuals living with bronchiectasis. Over the past ten years, significant advancements have been made in understanding the disease, with international registries enhancing our knowledge of disease burden and phenotypes. Updated guidelines and consensus statements have clarified standards of care, while new clinical trials have explored anti-inflammatory and anti-infective strategies. Additionally, advancements in airway clearance science, physiotherapy, digital health, imaging, and microbiome research are reshaping approaches to monitoring and preventing exacerbations.WBC 2026 will feature cutting-edge sessions addressing crucial topics such as treatable traits and endotypes, infection management, precision diagnostics, pediatric care, as well as physiotherapy and rehabilitation. Attendees can expect to engage with late-breaking trials and implementation science, all aimed at translating the latest research into better clinical practices. This conference is not only a homecoming for the bronchiectasis community but also a watershed moment to set the agenda for the next decade. It aims to accelerate therapeutic development, harmonize outcome measures, and ensure equitable access to high-quality care worldwide. Participants will have the opportunity to delve into research on genomics, diverse infections, and the impact of environmental factors, while exploring the latest therapeutic strategies. The WBC invites professionals from various fields to join in advancing science and enhancing clinical practice in order to improve the lives of those affected by bronchiectasis.